According to recent research, astrocyte cell transplantation could revolutionize treatments for neurological disorders such ...

A Risky Business: Why Do Some Parkinson's Disease Treatments Affect Decision Making? Sep. 24, 2024 — Parkinson's disease, a debilitating nervous system disorder, is treated with medications that ...

This year has seen several biopharma companies drop Alzheimer’s and Parkinson’s disease programs, but experts say plenty are ...

Early initiation of pimavanserin among patients with Parkinson disease psychosis were more likely to experience complete symptom resolution.

Among the symptoms, losing one's sense of smell could be an easily missed early indicator. The University of Auckland ...

Neurologist Jason Aldred helped conduct trials for the device in Spokane through his work at Selkirk Neurology, where he ...

A new study that aims to understand the genetics of Parkinson’s has been held up by the need for 7000 Australians without a ...

There is a new and promising form of treatment for those suffering from Parkinson’s Disease and it could be as simple as ...

About 7 million Americans live with chronic neurodegenerative diseases such as Parkinson’s disease, amyotrophic lateral ...

Researchers have identified unique RNA structures called G-quadruplexes (G4s) that promote harmful α-synuclein protein ...

Oct. 18, 2024 -- The FDA has approved a new injectable treatment for adults with advanced Parkinson’s disease called Vyalev (also known as Produodopa). This new option is designed to help people ...

The research team suggests that the treatment can help address very early stages of a condition such as Alzheimer’s or ...